According to Stock Talk (@stocktalkweekly), Morgan Stanley has upgraded Astera Labs ($ALAB) from 'Equalweight' to 'Overweight' with a $99 price target, citing attractive valuation following recent price movements and identifying multiple growth vectors such as ongoing hyperscale capex. For crypto traders, this bullish outlook on ALAB signals continued institutional investment in AI and data infrastructure, which often correlates with increased demand for blockchain and decentralized solutions as part of the broader tech growth trend. Source: Stock Talk (@stocktalkweekly), May 12, 2025.